Should HB 2357 pass, it would add another layer of restriction on sunscreen sales, which may facilitate public and environmental safety. The rationale behind these regulations stems from concerns that certain chemicals found in popular sunscreens can harm marine ecosystems. The legislation prevents counties from enacting their own regulations that may counter the state law, aiming for a unified approach to managing sunscreen constituents. Inevitably, this could influence local businesses that import or sell sunscreen products, particularly those that do not adhere to these new regulations.
House Bill 2357 aims to amend existing statutes regarding the sale and distribution of certain sunscreens in the state of Hawaii. Notably, the bill seeks to prohibit the sale of sunscreens containing avobenzone and octocrylene beginning January 1, 2024, unless they are prescribed by a licensed healthcare provider. This is set against a backdrop of previous restrictions on sunscreen ingredients such as oxybenzone and octinoxate that were already enforced starting January 1, 2021. The intent of this legislation appears to ensure that potentially harmful chemicals are regulated in the interest of protecting both public health and the marine environment.
The bill does face potential contention, particularly from retailers and manufacturers who may argue against the prescription requirement. Critics might raise concerns over accessibility and the practical implications of requiring a prescription for everyday items like sunscreen, viewing it as a regulatory overreach that complicates the purchasing process for consumers. Supporters of the bill may contend that the health benefits and environmental considerations outweigh these concerns, emphasizing the broader public interest in reduced chemical exposure.